Smooth muscle cells

Biomarker

3 papers3 findings

  • Animals3

Interventions

1

Navitoclax

downin mice1−90%

1 study
  1. Navitoclax decreases smooth muscle cells in mice (-90%).

    “However, ABT-263 treatment reduced SMC by 90% and increased EC contributions to lesions via EC-to-mesenchymal transition (EndoMT) by 60%.”

    Animalsin western diet-fed Apoe-/- mice with advanced atherosclerosisbrachiocephalic artery100 mg/kg/bw or 50 mg/kg/bw6 weeks or 9 weeks

    Treatment of advanced atherosclerotic mice with ABT-263 reduced indices of plaque stability and increased mortality

    JCI insight23 Jan 2024

More on Navitoclax

Upstream

2

FARNESYL-PRELAMINA

no changein mice1

1 study
  1. FARNESYL-PRELAMINA has no effect on smooth muscle cells in mice.

    “In contrast, farnesyl-prelamin A in Zmpste24 -/- mice does not cause SMC loss-even at 21 weeks of age.”

    AnimalsZmpste24 -/- miceaorta

    The Accumulation of Progerin Underlies the Loss of Aortic Smooth Muscle Cells in Hutchinson-Gilford Progeria Syndrome

    bioRxiv : the preprint server for biology3 Nov 2024Preprint

More on FARNESYL-PRELAMINA

LMNA

downin mice1

1 study
  1. LMNA decreases smooth muscle cells in mice.

    “In a mouse model of HGPS (Lmna G609G), progerin causes loss of aortic smooth muscle cells (SMCs) by ~12 weeks of age.”

    AnimalsLmna G609G miceaorta

    The Accumulation of Progerin Underlies the Loss of Aortic Smooth Muscle Cells in Hutchinson-Gilford Progeria Syndrome

    bioRxiv : the preprint server for biology3 Nov 2024Preprint

More on LMNA

Latest

Nov 2025: 18Dec 2025: 12Jan 2026: 9Feb 2026: 10Mar 2026: 9Apr 2026: 9May 2026: 13Jun 2026: 15Jul 2026: 16Aug 2026: 10Sep 2026: 13Oct 2026: 13147 in 12 months